2Niho Y, Kokinuma R. Phase Ⅱ study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced nonsmall cell lung cancer[J]. Lung Cancer, 2002, 35:209-214.
3Schiller J H, Harrington D, Belani C P, et al. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer [J].New Eng J Med, 2002,346(2):92-98.
4Le chavalier T, Berlle J, Zaleberg J R, et al. Overview of docetaxel (Taxotere) / cisplatin in non-small cell lung cancer [J]. Semin Oncol,1999, 26(supp Ⅱ ):13-18.
5Bunn P A, Soriano A F. Chemotherapeutic options in lung cancer[J].Cancer,1998,50(8):1740-1750.
6Fossella F V, Lee J S, Shin D M, et al. Phase Ⅱ study of docetaxel for advanced or metastatic platinum refractory non-small cell lung cancer[J]. J Clin Oncol, 1995, 13(3):645-651.
7Kim Y H, Kim J S, Choi Y H, et al. Phase Ⅱ study of docetaxel and cisplatin combination chemotherapy in metastatic or unrsectable localized non-small cell lung cancer[J]. Int J Clin Oncol, 2002, 7:114-199.
8Klastersky J, Sculier J P. Dose-finding study ofpaclitaxel plus cisplatin in patients with non-small cell lung cancer [J]. Lung Cancer,1995, 12(s):117-125.
